cilomilast has been researched along with warfarin in 4 studies
Studies (cilomilast) | Trials (cilomilast) | Recent Studies (post-2010) (cilomilast) | Studies (warfarin) | Trials (warfarin) | Recent Studies (post-2010) (warfarin) |
---|---|---|---|---|---|
162 | 13 | 42 | 36,573 | 2,143 | 14,728 |
Protein | Taxonomy | cilomilast (IC50) | warfarin (IC50) |
---|---|---|---|
Vitamin K epoxide reductase complex subunit 1 | Homo sapiens (human) | 0.0088 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Clark, DJ; Fuder, H; Kelly, J; Murdoch, RD; Webber, DM | 1 |
1 trial(s) available for cilomilast and warfarin
Article | Year |
---|---|
Warfarin pharmacodynamics unaffected by cilomilast.
Topics: Adult; Anticoagulants; Bronchodilator Agents; Carboxylic Acids; Cyclohexanecarboxylic Acids; Double-Blind Method; Drug Interactions; Humans; International Normalized Ratio; Male; Middle Aged; Nitriles; Phosphodiesterase Inhibitors; Warfarin | 2001 |
3 other study(ies) available for cilomilast and warfarin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |